110 related articles for article (PubMed ID: 37192718)
21. Coexpression network analysis coupled with connectivity map database mining reveals novel genetic biomarkers and potential therapeutic drugs for polymyositis.
Wang K; Zhu R; Li J; Zhang Z; Wen X; Chen H; Sun L
Clin Rheumatol; 2022 Jun; 41(6):1719-1730. PubMed ID: 35091780
[TBL] [Abstract][Full Text] [Related]
22. Identification of Transcriptional Pattern Related to Immune Cell Infiltration With Gene Co-Expression Network in Papillary Thyroid Cancer.
Li M; Zhang J; Zhang Z; Qian Y; Qu W; Jiang Z; Zhao B
Front Endocrinol (Lausanne); 2022; 13():721569. PubMed ID: 35185791
[TBL] [Abstract][Full Text] [Related]
23. Systemic characterization of alternative splicing related to prognosis and immune infiltration in malignant mesothelioma.
Lai J; Yang H; Xu T
BMC Cancer; 2021 Jul; 21(1):848. PubMed ID: 34294080
[TBL] [Abstract][Full Text] [Related]
24. Machine learning algorithms assisted identification of post-stroke depression associated biological features.
Zhang X; Wang X; Wang S; Zhang Y; Wang Z; Yang Q; Wang S; Cao R; Yu B; Zheng Y; Dang Y
Front Neurosci; 2023; 17():1146620. PubMed ID: 36968495
[TBL] [Abstract][Full Text] [Related]
25. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
[TBL] [Abstract][Full Text] [Related]
26. Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO penalization.
Liang R; Zhi Y; Zheng G; Zhang B; Zhu H; Wang M
Onco Targets Ther; 2019; 12():157-168. PubMed ID: 30613154
[TBL] [Abstract][Full Text] [Related]
27. CRISPR-cas9 screening identified lethal genes enriched in Hippo kinase pathway and of predictive significance in primary low-grade glioma.
Mijiti M; Maimaiti A; Chen X; Tuersun M; Dilixiati M; Dilixiati Y; Zhu G; Wu H; Li Y; Turhon M; Abulaiti A; Maimaitiaili N; Yiming N; Kasimu M; Wang Y
Mol Med; 2023 May; 29(1):64. PubMed ID: 37183261
[TBL] [Abstract][Full Text] [Related]
28. A Novel TAF-Related Signature Based on ECM Remodeling Genes Predicts Glioma Prognosis.
Wang LJ; Lv P; Lou Y
Front Oncol; 2022; 12():862723. PubMed ID: 35574375
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of oxidative stress-related lncRNA signatures in glioma reveals the discrepancy of prognostic and immune infiltration.
Shi Z; Wu Y; Zhuo Q; Zuo Y; Lin J; Shi H; Zhou H; Xu Z
Sci Rep; 2023 May; 13(1):7731. PubMed ID: 37173373
[TBL] [Abstract][Full Text] [Related]
30. Determination of a six-gene prognostic model for cervical cancer based on WGCNA combined with LASSO and Cox-PH analysis.
Li S; Han F; Qi N; Wen L; Li J; Feng C; Wang Q
World J Surg Oncol; 2021 Sep; 19(1):277. PubMed ID: 34530829
[TBL] [Abstract][Full Text] [Related]
31. Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.
Liu SH; Wang YL; Jiang SM; Wan XJ; Yan JH; Liu CF
Brain Res; 2022 Jun; 1785():147879. PubMed ID: 35278479
[TBL] [Abstract][Full Text] [Related]
32. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma.
Zhu J; Lin Q; Zheng H; Rao Y; Ji T
Front Oncol; 2022; 12():897042. PubMed ID: 36505882
[TBL] [Abstract][Full Text] [Related]
33. A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma.
Wu Z; Liu M; Fu J; Li J; Qin L; Wu L; Chen H; Yan X; Liu Q; Zheng J
Biomed Res Int; 2022; 2022():3742447. PubMed ID: 35757472
[TBL] [Abstract][Full Text] [Related]
34. Identification of Key Diagnostic Markers and Immune Infiltration in Osteoarthritis.
Yan M; Zhao H; Sun Z; Chen J; Zhang Y; Gao J; Yu T
Comb Chem High Throughput Screen; 2023; 26(2):410-423. PubMed ID: 35473522
[TBL] [Abstract][Full Text] [Related]
35. A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy.
Zeng Z; Hu C; Ruan W; Zhang J; Lei S; Yang Y; Peng P; Pan F; Chen T
Front Immunol; 2022; 13():1001381. PubMed ID: 36159801
[TBL] [Abstract][Full Text] [Related]
36. Integrated analysis of inflammatory response subtype-related signature to predict clinical outcomes, immune status and drug targets in lower-grade glioma.
Cao Y; Zhu H; Chen Q; Huang H; Xie D; Li X; Jiang X; Ren C; Peng J
Front Pharmacol; 2022; 13():914667. PubMed ID: 36091778
[No Abstract] [Full Text] [Related]
37. Interleukin 2 receptor subunit beta as a novel hub gene plays a potential role in the immune microenvironment of abdominal aortic aneurysms.
Gao H; Wang L; Ren J; Liu Y; Liang S; Zhang B; Sun X
Gene; 2022 Jun; 827():146472. PubMed ID: 35381314
[TBL] [Abstract][Full Text] [Related]
38. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
39. Analysis and Construction of a Molecular Diagnosis Model of Drug-Resistant Epilepsy Based on Bioinformatics.
Han T; Wu Z; Zhu J; Kou Y; Li J; Deng Y
Front Mol Biosci; 2021; 8():683032. PubMed ID: 34805265
[No Abstract] [Full Text] [Related]
40. Identification of key modules and hub genes for eosinophilic asthma by weighted gene co-expression network analysis.
Li F; Li M; Hu L; Zhu W; Cheng D
J Asthma; 2023 May; 60(5):1038-1049. PubMed ID: 36165511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
